Description:
Velasof is a fixed-dose combination of Sofosbuvir, a hepatitis C virus (HCV) nucleotide anaVelasof is a potent antiviral therapy designed to treat chronic Hepatitis C virus (HCV) infection. It combines velpatasvir and sofosbuvir, which act by blocking essential viral enzymes to halt replication.
Suitable for all major HCV genotypes, Velasof offers high cure rates with a simplified once-daily dosage. It is especially valued for its safety, minimal side effects, and convenience in achieving sustained virologic response (SVR). alog NS5B polymerase inhibitor, and Velpatasvir, an HCV NS5A inhibitor.
Share your experience with our medical product. Write a review!
25 Mar 2026
Transdermal Patches 2026: Latest Trends, Benefits & How They’re Revolutionizing Pain & Nicotine Relief
Transdermal patches are advanced drug delivery systems that deliver medication through the skin directly into the bloodstream. In 2026, new health technology trends are making transdermal patches more
14 Mar 2026
How Carica Papaya Leaf Extract Supports Platelet Recovery: Evidence, Uses & Best Practices
A healthy platelet count is essential for proper clotting, immune defense, and overall blood health. When platelet levels fall below normal-commonly referred to as low platelet count-the body becomes
05 Feb 2026
Food Habits That Increase Diabetes Risk - And How Fenugreek Can Help Manage Blood Sugar Naturally
Diet plays a crucial role in the development and management of type 2 diabetes.
20 Jan 2026
PCOS Symptoms and Management: Signs Most Women Overlook
Polycystic Ovary Syndrome (PCOS) is a common hormonal condition affecting millions of women worldwide. Early symptoms are often subtle and overlooked, which can delay diagnosis and treatment.
